Tylvalosin is a broad-spectrum macrolide antibiotic with both antibacterial and antiviral properties. Tylvalosin induces apoptosis, exerts anti-inflammatory effects, alleviates oxidative stress, and reduces acute lung injury by inhibiting the activation of NF-kappaB.
